Toxoplasmosis vaccine - Vaxinano
Latest Information Update: 15 Mar 2024
At a glance
- Originator Vaxinano
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Toxoplasmosis
Most Recent Events
- 14 Mar 2024 Early research in Toxoplasmosis in France (Intranasal), before March 2024 (Vaxinano website, March 2024)